Журнал «Общая реаниматология» опубликовал статью исследователей из московской ГКБ №1 имени Н.И. Пирогова и Федерального научно-клинического центра реаниматологии и реабилитологии (ФНКЦ РР), в которой описывается опыт применения устройств Эфферон...
Тезисы доклада «Исследование 1b фазы алофаниба, аллостерического ингибитора FGFR2, у пациентов с распространенным или метастатическим раком желудка» компании «Русфармтех» были отобраны и представлены на крупнейшем симпозиуме Американского...
22 октября в рамках форума «Открытые инновации» состоится официальная инаугурация Центра инноваций и интернета вещей в здравоохранении. Центр, созданный Фондом «Сколково» и ведущими российскими и международными компаниями, займется разработкой...
Сравнение работы человеческого сердца с часовым механизмом не страдает новизной, что, впрочем, не делает эту аналогию менее верной. Точно так же, как часы, вследствие изношенности механизма, со временем начинают отставать, человеческое сердце замедляет свой...
Исследователи из сколковского стартапа Gero, Сколтеха, МФТИ и Университета медицинских наук Арканзаса нашли способ повторно использовать большие данные о работе генов червей и выяснили, что старение нематод — это частично запрограммированный процесс,...
Skolkovo resident company 3D Bioprinting Solutions has become the first company to use a 3D printer to create live tissue in space, printing an organ construct for the thyroid gland of a mouse on board the International Space Station (ISS) this month. ...
Russian healthcare marked a major milestone on Wednesday with the opening of the branch of a top Israeli hospital at the Skolkovo innovation centre, meaning Russians can now access Israeli healthcare without having to leave the country. Prime Minister...
Rusbase, an independent website devoted to technology, business and investment, published a list on Tuesday of the top five most interesting biotech startups in Russia, and all are residents of the Skolkovo Foundation. An ExoAtlet pilot demonstrates the...
When the UNIM lab opened at the Skolkovo Technopark at the beginning of this year, it offered cancer patients around the country the chance to get expert opinions on their tumours by digitalizing slides and sending them to the world’s top specialists...
A pair of very special speakers took part in a conference devoted to 3D bioprinting in space at the Skolkovo innovation centre on Wednesday. Two cosmonauts – commander Anton Shkaplerov and flight engineer Oleg Artemyev – answered questions and interacted...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
Skolkovo resident 3D Bioprinting Solutions made headlines around the world in 2015 when it printed a functioning thyroid construct and transplanted it successfully into a mouse. Now it looks set to make history again by sending a bioprinter into space. 3D...
In a year in which supercomputer capacity records are sure to be smashed once again, the European Union has already said it will spend 1 billion euros this year on the machines, which can be used to calculate anything from weather forecasts and oil and gas...
A new lab opened at the Skolkovo Technopark on Wednesday that looks set to drastically improve the diagnosis of cancer patients across Russia. Russia’s first digital lab was opened by UNIM , a resident of Skolkovo’s biomed cluster that uses...
The Skolkovo Foundation has joined forces with the U.K.’s AMR Centre, a private-public initiative launched in 2016 to support and accelerate the development of new antibiotics, to combat the global problem of antimicrobial resistance. Skolkovo's...
The Skolkovo Foundation has signed a cooperation agreement with Janssen, a Belgium-headquartered subdivision of U.S. pharma giant Johnson & Johnson, with the aim of boosting innovative pharmaceutical research, including through financial support. Priority...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Russia’s first commercial research biobank, National BioService , opened a brand new laboratory at the Skolkovo Technopark on Thursday. The National BioService lab at the Skolkovo Technopark will be used for both the company's own research and...
Insilico Medicine , the parent company of Skolkovo resident biomed startup Insilico , has published a peer-review research paper calling for patients to regain control of their personal medical records, and even to profit from them. The Baltimore-based Insilico...
The first shared lab space in Russia for life sciences and biotech startups opened its doors at the Skolkovo Technopark on Wednesday with a mission to help budding biomed entrepreneurs test their theories and turn their ideas into a commercial company. ...
Pharm-Sintez.Lab , a resident startup of the Skolkovo Foundation’s nuclear cluster, has developed a system for detecting rare forms of cancer in Russian patients. Lev Voloznev, CEO of Pharm-Sintez.Lab, pictured in his lab at the Skolkovo Technopark...
Insilico Medicine, the parent company of Skolkovo biomed startup Insilico, has launched a beta 1.0 version of a system that will study aging at the population level and track the efficacy of anti-aging interventions, and could one day help to prevent diseases...
Advanced Gene & Cell Technologies (AGCT) , a resident startup of the Skolkovo Foundation’s biomed cluster, has received the first tranche of investment from the RBV Capital venture fund allocated to carry out Russia’s first clinical practice...
Whoopi Goldberg’s got it. Susan Sarandon has it. So has Dolly Parton, and they’re far from alone. An estimated 176 million women around the planet suffer from endometriosis, a condition in which tissue that normally grows inside the uterus (endometrium...
The fifth annual Startup Village, a giant open-air event for hi-tech entrepreneurs and investors, opened Tuesday at the Skolkovo innovation city with the signing of two key agreements. Philips' Henk de Jong brandishes the symbolic key given to him...